Related Experiment Video
Updated: Jul 25, 2026

07:32
Assessment of Vascular Regeneration in the CNS Using the Mouse Retina
Published on: June 23, 2014
[Retinopathy of prematurity: casuistics between 1996 and 2001]
N Grunauer1, M Iriondo Sanz, A Serra Castanera
1Sección de Neonatología. Unidad Integrada de Pediatría. Hospital Universitario Sant Joan de Déu. Barcelona. España. miriondo@hsjdbcn.org
Anales De Pediatria (Barcelona, Spain : 2003)
|May 2, 2003
Summary
Retinopathy of prematurity (ROP) affects 22.8% of premature infants, with incidence decreasing with higher gestational age and weight. Laser therapy showed optimal results for treating ROP.
Area of Science:
- Neonatal ophthalmology
- Perinatal medicine
- Public health
Background:
- Retinopathy of prematurity (ROP) is a significant cause of neurosensory impairment in premature infants.
- Understanding ROP's incidence and risk factors is crucial for early intervention and improved outcomes.
Purpose of the Study:
- To investigate the incidence, risk factors, treatment, and outcomes of ROP in infants born before 32 weeks gestation.
- To evaluate the effectiveness of laser therapy in managing ROP.
Main Methods:
- A descriptive study was conducted on premature infants (<= 32 weeks gestation) born between 1995 and 2001.
- Ocular evaluations were performed from 4-6 weeks of life, repeated bi-weekly until complete retinal vascularization.
- Bivariate analysis compared infants with and without ROP, assessing ocular sequelae and visual function.
Main Results:
- ROP incidence was 22.8% (74/324 infants), with 3.7% having stage 3 ROP.
- A significant inverse correlation was found between ROP incidence and gestational age/birth weight.
- Laser therapy yielded optimal results, with low rates of ocular sequelae (2.7%) and visual function alterations (1.7%).
Conclusions:
- The incidence of ROP in this cohort was comparable to other centers, strongly linked to identified risk factors.
- Severe ROP stages were not observed in infants born after 30 weeks gestation.
- Laser therapy proved effective, leading to better ocular and visual outcomes compared to untreated cases.

